The Best Weight Loss Injections in Kuwait: Mounjaro vs. Wegovy vs. Ozempic
If you want the absolute highest weight loss from an injection available in Kuwait today, the answer is Mounjaro. If you want the medication with the most proven heart benefits, the answer is Wegovy.
Both of these medications are now registered and available in local pharmacies across Kuwait. Thanks to recent Ministry of Health mandates, prices for these treatments have dropped by 30% to 37%. This makes them more accessible than ever, but choosing the right one can still feel overwhelming.
Let's look at the real numbers from clinical trials so you and your doctor can make the right choice.
Mounjaro: The heavy hitter for weight loss
Mounjaro (the brand name for tirzepatide) delivers the most potent weight loss of any approved injection. At the maximum dose, people lose roughly 20% of their body weight [surmount1_nejm].
How does it work so well? It comes down to its design. Mounjaro is what scientists call a "twincretin." It targets two different hormone receptors in your body at the same time: GIP and GLP-1.
The GLP-1 part reduces your appetite and slows down how fast your stomach empties. The GIP part improves how your body uses insulin and adds extra appetite suppression in the brain. Working together, these two mechanisms produce massive results.
In a massive 72-week study called SURMOUNT-1, researchers tested Mounjaro on over 2,500 adults with a body mass index (BMI) of 30 or higher. The results were staggering. People taking the highest dose (15 mg) lost an average of 20.9% of their body weight [surmount1_nejm]. For those who stuck strictly to the treatment, that number jumped to 22.5%—roughly 24 kilograms (52 pounds).
Here is what matters: 91% of people on the highest dose lost at least 5% of their weight, and more than half lost 20% or more.
The head-to-head battle: Mounjaro vs. Wegovy
For a long time, doctors had to guess which drug was better by comparing different studies. That changed in 2025 with the SURMOUNT-5 trial.
This was the first time researchers put Mounjaro and Wegovy in a direct, head-to-head comparison. They took 751 adults with obesity and gave half of them Mounjaro and the other half Wegovy for 72 weeks.
The primary result was decisive. People taking Mounjaro lost an average of 20.2% of their body weight. Those taking Wegovy lost 13.7% [surmount5_nejm]. That is a massive 6.5 percentage-point difference. Mounjaro simply strips away more fat.
Wegovy: The heart-protective choice
If Mounjaro causes more weight loss, why would anyone choose Wegovy? The short answer is heart health.
Wegovy (semaglutide) targets only the GLP-1 receptor. While it doesn't match Mounjaro's weight loss numbers, it has something Mounjaro currently lacks: hard proof that it prevents heart attacks.
In a landmark study called the SELECT trial, researchers proved that Wegovy reduces the risk of heart attacks and strokes by 20% in people with heart disease [select_trial]. Because of this, Wegovy is the only GLP-1 weight-loss drug officially approved to reduce cardiovascular risk. If you have a history of heart issues, your cardiologist will likely point you toward Wegovy.
That said, Wegovy is still highly effective for shedding kilos. In the STEP 1 trial, people taking the maximum 2.4 mg dose of Wegovy lost an average of 14.9% of their body weight over 68 weeks [step1_nejm]. Half of the people in that study lost at least 15% of their starting weight.
Worth noting: Wegovy takes time to build up in your system. You start on a tiny 0.25 mg dose and slowly increase it every four weeks. It takes a full 16 weeks to reach the target 2.4 mg dose. This slow build-up helps your stomach get used to the medicine and keeps nausea manageable.
Ozempic and Saxenda: Where do they fit?
You have probably heard of Ozempic. You might even know people taking it for weight loss.
Here is the reality: Wegovy and Ozempic are the exact same medicine. They are both semaglutide, made by the same company. But they have entirely different missions.
Ozempic is approved exclusively for type 2 diabetes. Its maximum dose is 2.0 mg. Wegovy is approved for weight loss, and its maximum dose is 2.4 mg.
Because insurance often covers Ozempic for diabetes but denies Wegovy for weight loss, many doctors prescribe Ozempic "off-label" to help people lose weight. In fact, roughly one-third of all Ozempic prescriptions go to people who do not have diabetes [trilliant_health]. This massive off-label demand is what caused the global Ozempic shortage over the last few years.
If you have type 2 diabetes, Ozempic is a fantastic choice. Just know that people with diabetes generally lose less weight on these medications than people without diabetes. In the STEP 2 trial, people with diabetes taking the 2.4 mg dose lost 9.6% of their body weight, compared to the 14.9% seen in people without diabetes [step2_nejm].
You might also hear about Saxenda. This is an older GLP-1 medication. Unlike Wegovy and Mounjaro, which you inject once a week, Saxenda requires a daily injection. It also produces much less weight loss—usually around 5% to 8%. While it is still available in Kuwait, most doctors now prefer the newer, weekly options unless there is a specific medical or insurance reason to use Saxenda.
Living with weight loss injections in Kuwait
Taking these medications in Kuwait comes with a few unique local challenges.
Managing the summer heat Kuwait's extreme summer temperatures can easily destroy these medications. Both Mounjaro and Wegovy are sensitive biological peptides. They must be kept refrigerated between 2°C and 8°C before their first use.
If you pick up your prescription from a pharmacy in Hawally or Salmiya in July, do not leave the pens in your car while you run other errands. The heat inside a parked car will ruin the medication in minutes. Take an insulated cooler bag to the pharmacy, and put the pens straight into your fridge at home.
Fasting during Ramadan Fasting while taking a GLP-1 medication requires careful planning. These drugs work by slowing down how fast your stomach empties.
When you break your fast at Iftar, your stomach is already processing food much slower than normal. If you eat a large, heavy meal quickly, you will likely feel very sick. Nausea is the most common side effect of these drugs, and overeating makes it much worse.
In practice, you need to break your fast slowly. Start with water and a date, wait a bit, and eat a small portion. Hydration is also critical. Because you are not drinking water during the day, and the medication can sometimes blunt your thirst, you must make a conscious effort to drink plenty of water between Iftar and Suhoor to protect your kidneys.
Common Questions
Which injection is actually the best? If your primary goal is maximum weight loss, Mounjaro is the most effective option available, averaging around 20% weight reduction. If you have a history of heart disease or stroke, Wegovy is currently the better choice because it is proven to reduce cardiovascular events by 20%.
What happens if I stop taking the injection? You will likely regain the weight. In the SURMOUNT-4 trial, people who took Mounjaro for 36 weeks and then switched to a placebo regained 14% of their body weight over the next year [surmount4_jama]. These are chronic medications designed for long-term use, much like blood pressure pills.
Can I switch from Ozempic to Mounjaro or Wegovy? Yes, doctors frequently switch patients between these medications, especially if someone hits a weight-loss plateau or struggles with side effects. However, you cannot just swap them on your own. Your doctor will need to calculate the correct starting dose for the new medication to prevent severe stomach issues.
Do I need a prescription to buy these in Kuwait? Yes. While they are stocked in major private pharmacies across Kuwait, both Mounjaro and Wegovy are prescription-only medications. You need to consult with a doctor who will check your BMI, run basic blood tests, and ensure the medication is safe for you.
Related Pages * Wegovy vs Ozempic: What is the difference? * Wegovy vs Mounjaro: Head-to-head comparison * Wegovy vs Saxenda: Weekly vs daily injections * Wegovy vs Bariatric Surgery: Which is right for you?
*
This article is based on the Kuwait HA-approved Wegovy leaflet (revised September 2024) and published clinical evidence. It does not replace advice from your doctor.